Weisi Medical said on September 2 that shareholder Hu Ping, who holds more than 5% of the company, plans to reduce his stake by no more than 1.9154 million shares, or 2% of total share capital, between September 24, 2026 and December 22, 2026. The shares may be sold through block trades and centralized bidding, with no price range set, and the reason given was personal funding needs, according to Jiemian News. Based on the September 1 closing price of 45.46 yuan per share, the planned sale would be worth up to about 87.0752 million yuan.